Inhibition of Alpha Interferon (IFN- )-Induced MicroRNA-122 Negatively Affects the Anti-Hepatitis B Virus Efficiency of IFN- 

Modulation of the Unfolded Protein Response Is the Core of MicroRNA-122-Involved Sensitivity to Chemotherapy in Hepatocellular Carcinoma

(2015) Fu Yang et al.   NEOPLASIA

The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression

(2014) J.-H. Kim et al.   JOURNAL OF IMMUNOLOGY

Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line

(2012) L.Y. Wang et al.   GENETICS AND MOLECULAR RESEARCH

The Role of MicroRNAs in Cholesterol Efflux and Hepatic Lipid Metabolism

(2011) Kathryn J. Moore et al.   Annual Review of Nutrition

Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice

(2011) Marc Lütgehetmann et al.   GASTROENTEROLOGY

Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1-modulated P53 activity

(2011) Saifeng Wang et al.   HEPATOLOGY

Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122

(2011) Daniel R. Boutz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR

(2011) Y.-P. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of Interferon-α/β on HBV Replication Determined by Viral Load

(2011) Yongjun Tian et al.   PLoS Pathogens

miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV

(2010) Lipeng Qiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Liver-enriched transcription factors regulate MicroRNA-122 that targets CUTL1 during liver development

(2010) Hui Xu et al.   HEPATOLOGY

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

(2010) Milan J. Sonneveld et al.   HEPATOLOGY

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

(2010) Chunxian Zeng et al.   HEPATOLOGY

RNAi-mediated downregulation of uPAR synergizes with targeting of HER2 through the ERK pathway in breast cancer cells

(2010) Changfei Li et al.   INTERNATIONAL JOURNAL OF CANCER

Mechanisms of HBV-related hepatocarcinogenesis

(2010) Christine Neuveut et al.   JOURNAL OF HEPATOLOGY

Indoleamine 2,3-Dioxygenase Mediates the Antiviral Effect of Gamma Interferon against Hepatitis B Virus in Human Hepatocyte-Derived Cells

(2010) R. Mao et al.   JOURNAL OF VIROLOGY

Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus

(2010) C. Xu et al.   JOURNAL OF VIROLOGY

MicroRNA sponges: Progress and possibilities

(2010) M. S. Ebert et al.   RNA

MicroRNA Antagonism of the Picornaviral Life Cycle: Alternative Mechanisms of Interference

(2010) Elizabeth J. Kelly et al.   PLoS Pathogens

Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa

(2009) Erik H.C.J. Buster et al.   GASTROENTEROLOGY

Integration of microRNA miR-122 in hepatic circadian gene expression

(2009) D. Gatfield et al.   GENES & DEVELOPMENT

Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-α/β, IFN-γ, and IFN-λ in host defense

(2009) Shen-Ying Zhang et al.   IMMUNOLOGICAL REVIEWS

Methylation Regulates Hepatitis B Viral Protein Expression

(2009) Perumal Vivekanandan et al.   JOURNAL OF INFECTIOUS DISEASES

Differential Transcriptional Responses to Interferon-α and Interferon-γ in Primary Human Hepatocytes

(2009) Xiao-Song He et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Modulation of Hepatitis C Virus RNA Abundance and the Isoprenoid Biosynthesis Pathway by MicroRNA miR-122 Involves Distinct Mechanisms

(2009) K. L. Norman et al.   JOURNAL OF VIROLOGY

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

(2009) Magdalena Sarasin-Filipowicz et al.   NATURE MEDICINE

Cytosolic 5′-nucleotidase III (NT5C3): gene sequence variation and functional genomics

(2009) Pinar Aksoy et al.   Pharmacogenetics and Genomics

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

Clinical significance of 4 patients with chronic hepatitis B achieving HBsAg clearance by treated with pegylated interferon alpha-2a for less than 1 year: a short report

(2009) Jin Yang et al.   Virology Journal

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

(2008) Rami Moucari et al.   HEPATOLOGY

ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis B

(2008) M.J. ter Borg et al.   JOURNAL OF CLINICAL VIROLOGY

miR-122, a paradigm for the role of microRNAs in the liver

(2008) Muriel Girard et al.   JOURNAL OF HEPATOLOGY

APOBEC3-Independent Interferon-Induced Viral Clearance in Hepatitis B Virus Transgenic Mice

(2008) P. Turelli et al.   JOURNAL OF VIROLOGY

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alphain vitro

(2007) Quan Zhang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY